Petrus Bekker, SVP of Medical & Clinical at ChemoCentryx, Inc. (CCXI), sold 8,388 shares at $14.00 ($117K) on 2013-03-12, disclosed to the SEC on 2013-03-14.
Scheduled sale ($117k) by SVP of Medical & Clinical under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 4,276 | $60K | 51.0% |
| 2 | $14.00 | 3,212 | $45K | 38.3% |
| 3 | $14.00 | 900 | $13K | 10.7% |
| Total | $14.00 avg | 8,388 | $117K | 100% |
| Filing → |
| CCXI | SELL | 2017-06-30 | $760K | — | Filing → |
| CCXI | SELL | 2016-12-20 | $134K | — | Filing → |
| CCXI | SELL | 2016-12-07 | $255K | — | Filing → |